319 related articles for article (PubMed ID: 16390346)
1. N-acetylcysteine -- passe-partout or much ado about nothing?
Aitio ML
Br J Clin Pharmacol; 2006 Jan; 61(1):5-15. PubMed ID: 16390346
[TBL] [Abstract][Full Text] [Related]
2. [Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
Gillissen A
Pneumologie; 2011 Sep; 65(9):549-57. PubMed ID: 21761386
[TBL] [Abstract][Full Text] [Related]
3. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.
Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS
Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
6. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
8. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
[TBL] [Abstract][Full Text] [Related]
9. A minireview on N-acetylcysteine: An old drug with new approaches.
Elbini Dhouib I; Jallouli M; Annabi A; Gharbi N; Elfazaa S; Lasram MM
Life Sci; 2016 Apr; 151():359-363. PubMed ID: 26946308
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
12. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine.
Jugg B; Fairhall S; Smith A; Rutter S; Mann T; Perrott R; Jenner J; Salguero J; Shute J; Sciuto AM
Clin Toxicol (Phila); 2013 May; 51(4):216-24. PubMed ID: 23547745
[TBL] [Abstract][Full Text] [Related]
14. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.
Raghu G; Berk M; Campochiaro PA; Jaeschke H; Marenzi G; Richeldi L; Wen FQ; Nicoletti F; Calverley PMA
Curr Neuropharmacol; 2021; 19(8):1202-1224. PubMed ID: 33380301
[TBL] [Abstract][Full Text] [Related]
15. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Gillissen A; Nowak D
Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of N-acetylcysteine.
Kelly GS
Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury.
Sun Y; Pu LY; Lu L; Wang XH; Zhang F; Rao JH
World J Gastroenterol; 2014 Nov; 20(41):15289-98. PubMed ID: 25386077
[TBL] [Abstract][Full Text] [Related]
18. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine.
Altern Med Rev; 2000 Oct; 5(5):467-71. PubMed ID: 11056417
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
